SYRS - Syros Pharmaceuticals EPS beats by $0.03 beats on revenue May, 07 2020 07:34 AM Syros Pharmaceuticals Inc. Syros Pharmaceuticals (NASDAQ:SYRS): Q1 GAAP EPS of -$0.39 beats by $0.03.More news on: Syros Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...